Skip to main content
Clinical Trials/ISRCTN16797778
ISRCTN16797778
Completed
未知

Pilot study of a cognitive behavior therapy for adults with mild or borderline intellectual disabilities (MBID) and substance use disorders (SUD)

Aveleijn0 sites20 target enrollmentJanuary 3, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Participants with MBID with a history of Substance Use Disorder (SUD) who were referred to an outpatient SUD treatment facility
Sponsor
Aveleijn
Enrollment
20
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2019 Thesis results in https://repository.ubn.ru.nl/handle/2066/200654 (added 07/01/2022)

Registry
who.int
Start Date
January 3, 2018
End Date
February 1, 2017
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Aveleijn

Eligibility Criteria

Inclusion Criteria

  • Between June 2014 and September 2015 twenty\-three participants with MBID with a history of SUD who were referred to an outpatient SUD treatment facility were included. Criteria for inclusion in this study were:
  • 1\. Dutch as a first language
  • 2\. Sufficient oral communication skills (i.e., fluent verbal speakers)
  • 3\. A mild to borderline intellectual disability (i.e., full scale IQ between 50 – 85 according to DSM\-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers)
  • 4\. Older than 18 years of age
  • Participants had no restrictions in remaining in other mental health treatment that they were currently receiving (e.g. EMDR or medication management)

Exclusion Criteria

  • 1\. Non\-Dutch speaking
  • 2\. Insufficient oral communication skills
  • 3\. A moderate or severe intellectual disability (i.e., full scale IQ below 50\) or a normal intelligence according to DSM\-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers)
  • 4\. Younger than 18 years of age
  • 5\. Serious psychiatric illnesses with a chance to decompensate

Outcomes

Primary Outcomes

Not specified

Similar Trials